Back to Report Store Home

Renal Diseases Drug Development Pipeline Review, 2018

  • Published: Dec-2018
  • Report Code: GBIHC052IDB
  • Report Format: pdf

Description

List of Tables

Table 1: Number of Products under Development for Chronic Kidney Disease (Chronic Renal Failure)

Table 2: Number of Products under Development by Companies, Chronic Kidney Disease (Chronic Renal Failure)

Table 3: Number of Products under Development by Universities/Institutes, Chronic Kidney Disease (Chronic Renal Failure)

Table 4: Products under Development by Companies, Chronic Kidney Disease (Chronic Renal Failure)

Table 5: Products under Development by Universities/Institutes, Chronic Kidney Disease (Chronic Renal Failure)

Table 6: Number of Products under Development for Kidney Fibrosis

Table 7: Number of Products under Development by Companies, Kidney Fibrosis

Table 8: Number of Products under Development by Universities/Institutes, Kidney Fibrosis

Table 9: Products under Development by Companies, Kidney Fibrosis

Table 10: Products under Development by Universities/Institutes, Kidney Fibrosis

Table 11: Number of Products under Development for Polycystic Kidney Disease, Kidney Fibrosis

Table 12: Number of Products under Development by Companies, Kidney Fibrosis

Table 13: Number of Products under Development by Universities/Institutes, Kidney Fibrosis

Table 14: Products under Development by Companies, Kidney Fibrosis

Table 15: Products under Development by Universities/Institutes, Kidney Fibrosis

Table 16: Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 17: Number of Products under Development by Companies, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 18: Products under Development by Companies, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 19: Number of Products by Stage and Target, Chronic Kidney Disease (Chronic Renal Failure)

Table 20: Number of Products by Stage and Mechanism of Action, Chronic Kidney Disease (Chronic Renal Failure)

Table 21: Number of Products by Stage and Route of Administration, Chronic Kidney Disease (Chronic Renal Failure)

Table 22: Number of Products by Stage and Molecule Type, Chronic Kidney Disease (Chronic Renal Failure)

Table 23: Number of Products by Stage and Target, Kidney Fibrosis

Table 24: Number of Products by Stage and Mechanism of Action, Kidney Fibrosis

Table 25: Number of Products by Stage and Route of Administration, Kidney Fibrosis

Table 26: Number of Products by Stage and Molecule Type, Kidney Fibrosis

Table 27: Number of Products by Stage and Target, Polycystic Kidney Disease

Table 28: Number of Products by Stage and Mechanism of Action, Polycystic Kidney Disease

Table 29: Number of Products by Stage and Route of Administration, Polycystic Kidney Disease

Table 30: Number of Products by Stage and Molecule Type, Polycystic Kidney Disease

Table 31: Number of Products by Stage and Target, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 32: Number of Products by Stage and Mechanism of Action, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 33: Number of Products by Stage and Route of Administration, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 34: Number of Products by Stage and Molecule Type, End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)

Table 35: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Allena Pharmaceuticals Inc

Table 36: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Angion Biomedica Corp

Table 37: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by apceth Biopharma GmbH

Table 38: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Arch Biopartners Inc

Table 39: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Astellas Pharma Inc

Table 40: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by AstraZeneca Plc

Table 41: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Bayer AG

Table 42: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Boehringer Ingelheim GmbH

Table 43: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Boryung Pharmaceutical Co Ltd

Table 44: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Cellmid Ltd

Table 45: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Corvidia Therapeutics Inc

Table 46: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by DiaMedica Therapeutics Inc

Table 47: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Dimerix Bioscience Pty Ltd

Table 48: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by DURECT Corp

Table 49: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Evotec AG

Table 50: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by GNI Group Ltd

Table 51: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by KBP BioSciences Co Ltd

Table 52: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Klotho Therapeutics Inc

Table 53: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Nash Pharmaceuticals Inc

Table 54: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Novartis AG

Table 55: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by OPKO Health Inc

Table 56: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Opsidio LLC

Table 57: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Otsuka Holdings Co Ltd

Table 58: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Prolong Pharmaceuticals LLC

Table 59: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by ProMetic Life Sciences Inc

Table 60: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Reata Pharmaceuticals Inc

Table 61: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Resverlogix Corp

Table 62: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Sanwa Kagaku Kenkyusho Co Ltd

Table 63: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Sarfez Pharmaceuticals Inc

Table 64: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Sphaera Pharma Pte Ltd

Table 65: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Taisho Pharmaceutical Holdings Co Ltd

Table 66: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Theravance Biopharma Inc

Table 67: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Unity Biotechnology Inc

Table 68: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Vascular BioSciences

Table 69: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by VESSL Therapeutics Ltd

Table 70: Chronic Kidney Disease (Chronic Renal Failure) – Pipeline by Vicore Pharma AB

Table 71: Kidney Fibrosis – Pipeline by AdAlta Ltd

Table 72: Kidney Fibrosis – Pipeline by Angion Biomedica Corp

Table 73: Kidney Fibrosis – Pipeline by BiOrion Technologies BV

Table 74: Kidney Fibrosis – Pipeline by Cellmid Ltd

Table 75: Kidney Fibrosis – Pipeline by Certa Therapeutics Pty Ltd

Table 76: Kidney Fibrosis – Pipeline by Epigen Biosciences Inc

Table 77: Kidney Fibrosis – Pipeline by Evotec AG

Table 78: Kidney Fibrosis – Pipeline by Galectin Therapeutics Inc

Table 79: Kidney Fibrosis – Pipeline by GenKyoTex SA

Table 80: Kidney Fibrosis – Pipeline by Genzyme Corp

Table 81: Kidney Fibrosis – Pipeline by iBio Inc

Table 82: Kidney Fibrosis – Pipeline by Isarna Therapeutics GmbH

Table 83: Kidney Fibrosis – Pipeline by Kadmon Corp LLC

Table 84: Kidney Fibrosis – Pipeline by Les Laboratoires Servier SAS

Table 85: Kidney Fibrosis – Pipeline by Nash Pharmaceuticals Inc

Table 86: Kidney Fibrosis – Pipeline by Novo Nordisk AS

Table 87: Kidney Fibrosis – Pipeline by Pharmaxis Ltd

Table 88: Kidney Fibrosis – Pipeline by ProMetic Life Sciences Inc

Table 89: Kidney Fibrosis – Pipeline by Redx Pharma Plc

Table 90: Kidney Fibrosis – Pipeline by Regulus Therapeutics Inc

Table 91: Kidney Fibrosis – Pipeline by Scholar Rock Inc

Table 92: Kidney Fibrosis – Pipeline by Sirnaomics Inc

Table 93: Kidney Fibrosis – Pipeline by Symic Biomedical Inc

Table 94: Kidney Fibrosis – Pipeline by Vascular Biogenics Ltd

Table 95: Polycystic Kidney Disease – Pipeline by Angion Biomedica Corp

Table 96: Polycystic Kidney Disease – Pipeline by Celgene Corp

Table 97: Polycystic Kidney Disease – Pipeline by Conatus Pharmaceuticals Inc

Table 98: Polycystic Kidney Disease – Pipeline by DiscoveryBiomed Inc

Table 99: Polycystic Kidney Disease – Pipeline by Genzyme Corp

Table 100: Polycystic Kidney Disease – Pipeline by IC-MedTech Inc

Table 101: Polycystic Kidney Disease – Pipeline by Ipsen SA

Table 102: Polycystic Kidney Disease – Pipeline by Kadmon Corp LLC

Table 103: Polycystic Kidney Disease – Pipeline by ManRos Therapeutics

Table 104: Polycystic Kidney Disease – Pipeline by Mironid Ltd

Table 105: Polycystic Kidney Disease – Pipeline by NovaTarg Therapeutics Inc

Table 106: Polycystic Kidney Disease – Pipeline by Q BioMed Inc

Table 107: Polycystic Kidney Disease – Pipeline by Reata Pharmaceuticals Inc

Table 108: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline by Novartis AG

Table 109: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline by Prolong Pharmaceuticals LLC

Table 110: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Pipeline by VESSL Therapeutics Ltd

Table 111: Chronic Kidney Disease (Chronic Renal Failure) – Dormant Projects

Table 112: Kidney Fibrosis – Dormant Projects

Table 113: Polycystic Kidney Disease – Dormant Projects

Table 114: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Dormant Projects

Table 115: Chronic Kidney Disease (Chronic Renal Failure) – Discontinued Products

Table 116: Kidney Fibrosis – Discontinued Products

Table 117: Polycystic Kidney Disease – Discontinued Products

Table 118: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) – Discontinued Products

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3995
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7990
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$11985
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards